Investor mix
6 investors on record; lead investors include Third Rock Ventures, Takeda.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 17% |
| Private equity | 1 | 17% |
| Other / undisclosed | 4 | 67% |
Developer of cell therapies to treat severe liver diseases
6 investors on record; lead investors include Third Rock Ventures, Takeda.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 17% |
| Private equity | 1 | 17% |
| Other / undisclosed | 4 | 67% |